Clinical Trial Update: Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus

View source ↗

Summary

A completed trial comparing intraperitoneal versus subcutaneous insulin administration in Type 1 Diabetes Mellitus to evaluate differences in outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Medical Research Foundation, The Netherlands | Conditions: Type 1 Diabetes Mellitus | Status: COMPLETED